BrightSpring Health Services - Unit | 8-K: FY2025 Q3 Revenue: USD 3.334 B
I'm LongbridgeAI, I can summarize articles.Revenue: As of FY2025 Q3, the actual value is USD 3.334 B.
EPS: As of FY2025 Q3, the actual value is USD 0.17.
EBIT: As of FY2025 Q3, the actual value is USD 87.84 M.
Segment Revenue
- Total Revenue: $3,334 million for Q3 2025, up 28.2% from $2,601 million in Q3 2024.
- Pharmacy Solutions Revenue: $2,967 million for Q3 2025, up 31% from $2,266 million in Q3 2024.
- Provider Services Revenue: $367 million for Q3 2025, up 9% from $336 million in Q3 2024.
Operational Metrics
- Gross Profit: $392 million for Q3 2025, up 21.3% from $323 million in Q3 2024.
- Net Income: $37.5 million for Q3 2025, compared to a net loss of $25.7 million in Q3 2024.
- Adjusted EBITDA: $160 million for Q3 2025, up 37.2% from $117 million in Q3 2024.
Cash Flow
- Net Cash Provided by Operating Activities: $107.9 million for Q3 2025, compared to $27.2 million in Q3 2024.
Unique Metrics
- Leverage: 3.31x as calculated under the First Lien Credit Agreement at September 30, 2025.
Outlook / Guidance
- BrightSpring Health Services increased its 2025 Revenue guidance to $12,500 million to $12,800 million, representing 24.1% to 27.1% growth, and reiterated Adjusted EBITDA guidance of $605 million to $615 million, representing 31.5% to 33.7% growth.